Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2019, Article ID 4049287, 8 pages
https://doi.org/10.1155/2019/4049287
Research Article

Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software

1Department of Radiology, Leiden University Medical Center, Leiden, Netherlands
2Technical Medicine, University of Twente, Enschede, Netherlands
3Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
4Biomedical Photonic Imaging Group, TechMed Centre, University of Twente, Enschede, Netherlands
5Department of Robotics and Mechatronics, University of Twente, Enschede, Netherlands

Correspondence should be addressed to P. Hendriks; ln.cmul@skirdneh.p

Received 25 April 2019; Revised 13 July 2019; Accepted 28 August 2019; Published 19 September 2019

Academic Editor: Roberto Iezzi

Copyright © 2019 P. Hendriks et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Forner, J. M. Llovet, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 379, no. 9822, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Livraghi, F. Meloni, M. Di Stasi et al., “Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?” Hepatology, vol. 47, no. 1, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer, “EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma,” Journal of Hepatology, vol. 48, no. 4, pp. 599–641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-M. Lin, C. J. Lin, C. C. Lin, C. W. Hsu, and Y. C. Chen, “Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less,” Gut, vol. 54, no. 8, pp. 1151–1156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Morimoto, K. Numata, M. Kondou, A. Nozaki, S. Morita, and K. Tanaka, “Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma,” Cancer, vol. 116, no. 23, pp. 5452–5460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hänsler, M. Frieser, V. Tietz et al., “Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes,” Journal of Vascular and Interventional Radiology, vol. 18, no. 3, pp. 405–410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Hori, K. Nagata, S. Hasuike et al., “Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation,” Journal of Gastroenterology, vol. 38, no. 10, pp. 977–981, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Crocetti, T. de Baere, and R. Lencioni, “Quality improvement guidelines for radiofrequency ablation of liver tumours,” CardioVascular and Interventional Radiology, vol. 33, no. 1, pp. 11–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Colecchia, R. Schiumerini, A. Cucchetti et al., “Prognostic factors for hepatocellular carcinoma recurrence,” World Journal of Gastroenterology, vol. 20, no. 20, pp. 5935–5950, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Nakazawa, S. Kokubu, A. Shibuya et al., “Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin,” American Journal of Roentgenology, vol. 188, no. 2, pp. 480–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Liao, X. Zhong, J. Zhang et al., “Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: a prospective randomized trial,” Journal of Surgical Oncology, vol. 115, no. 8, pp. 971–979, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-S. Kim, W. J. Lee, H. Rhim, H. K. Lim, D. Choi, and J. Y. Lee, “The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion,” American Journal of Roentgenology, vol. 195, no. 3, pp. 758–765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Viera and J. M. Garrett, “Understanding interobserver agreement: the kappa statistic,” Family Medicine, vol. 37, no. 5, pp. 360–363, 2005. View at Google Scholar
  14. K. W. Kim, J. M. Lee, E. Klotz et al., “Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images,” American Journal of Roentgenology, vol. 196, no. 5, pp. W565–W572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Tani, S. Tatli, N. Hata et al., “Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map,” International Journal of Computer Assisted Radiology and Surgery, vol. 11, no. 6, pp. 1133–1142, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Farina, N. Weiss, Y. Nissenbaum et al., “Characterisation of tissue shrinkage during microwave thermal ablation,” International Journal of Hyperthermia, vol. 30, no. 7, pp. 419–428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Rossmann, E. Garrett-Mayer, F. Rattay, and D. Haemmerich, “Dynamics of tissue shrinkage during ablative temperature exposures,” Physiological Measurement, vol. 35, no. 1, pp. 55–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Brace, T. A. Diaz, J. L. Hinshaw, and F. T. Lee Jr., “Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung,” Journal of Vascular and Interventional Radiology, vol. 21, no. 8, pp. 1280–1286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Y. Tak, S.-M. Lin, Y. Wang et al., “Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions,” Clinical Cancer Research, vol. 24, no. 1, pp. 73–83, 2018. View at Publisher · View at Google Scholar · View at Scopus